NCT04369833

Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform

Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform Based on Artificial Intelligence Model Using Mathematical Analysis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 130 (actual)
• Sponsor: Pusan National University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to collect a variety of clinical data and blood glucose changes using a continuous glucose monitoring device for high-risk diabetes patients (prediabetes) in order to develop a personalized diabetes prevention and management platform based on artificial intelligence model using mathematical analysis.

Detailed description

After being informed about the study and potential risks, all patients giving written informed consent wear a continuous glucose monitoring device ("iPro2" professional continuous glucose monitoring, MedtronicⓇ, California, USA) and smart band ("Fitbit Inspire HR", FitbitⓇ, California, USA) for 1 week. During this period, all patients are tested oral glucose tolerance test and take a standard diet (calorie calculated) at morning. The patient's data from this study is compared to a predicted values by mathematical analysis model for diabetes prevention.

Conditions

• PreDiabetes
• Glucose Metabolism Disorders
• Diabetes Mellitus

Interventions

Type	Name	Description
DEVICE	continuous glucose monitoring system	wearing continuous glucose monitoring device (iPro2 professional continuous glucose monitoring, MedtronicⓇ, California, USA)

Timeline

• Start date: 2020-05-11
• Primary completion: 2020-09-30
• Completion: 2020-09-30
• First posted: 2020-04-30
• Last updated: 2022-05-09
• Results posted: 2022-05-09

Locations

1 site across 1 country: South Korea